Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

10,938 total articles

Buy Reiterated: Opakalim License Boosts Near-Term Upside for Biohaven

Buy Reiterated: Opakalim License Boosts Near-Term Upside for Biohaven

Biohaven shares trade near $15.90 after a pullback; a recently announced Opakalim licensing deal for epilepsy (terms limited) plus multiple 2026 clinical readouts and a still-meaningful cash position support a mid-term, catalyst-driven long. Market cap (~$2.4B), negative EPS (-$4.29), and steep cash burn keep this as a high-risk trade with clearly …

T-Mobile: A Focused Long Trade on the Most Competitive U.S. Carrier

T-Mobile: A Focused Long Trade on the Most Competitive U.S. Carrier

T-Mobile remains the most aggressive and efficient U.S. wireless operator: double-digit service revenue growth, strong free cash flow, a 2.2% yield and an attractive EV/EBITDA multiple. After Q2 volatility and a near-term ex-dividend, the stock offers a defined-risk entry for a mid-term swing trade targeting a re-rating toward prior trading ranges.

InfuSystem Has Room to Run: Swing Trade Into Improving Fundamentals

InfuSystem Has Room to Run: Swing Trade Into Improving Fundamentals

InfuSystem (INFU) looks poised for a mid-term rally. The company is generating free cash flow, has manageable leverage and recent operational improvements in Device Solutions and oncology are translating into margin expansion. At a market cap near $238M and EV/EBITDA under 10, upside to $14.50 within the next 45 trading days looks attainable. Entry…

AT&T: Cheap Cash Flow, Big Yield — A Low-Drama Way to Capture Upside

AT&T: Cheap Cash Flow, Big Yield — A Low-Drama Way to Capture Upside

AT&T is priced like a slow-growth utility but still generates meaningful cash flow and covers a chunky dividend. At $25.52 shares trade at roughly 8x earnings and an EV/EBITDA near 6.5 — valuations that don't require heroic operational improvement for a 20%+ move. This trade idea lays out a mid-term swing entry with concrete levels, catalysts, and …

Foster (FSTR): H2 Recovery + Higher-Margin Mix Should Re-rate the Stock

Foster (FSTR): H2 Recovery + Higher-Margin Mix Should Re-rate the Stock

L.B. Foster (FSTR) is a small-cap industrial with accelerating Rail and Infrastructure revenue, improving margin mix, and a compact balance sheet. Recent results and investor presentations point to a second-half recovery. At roughly $395M market cap, an EV/sales of 0.78 and about $47M in free cash flow suggest upside if management converts backlog …

Why I Sold Strategy (MSTR) and Put Money Elsewhere - A Short Trade Plan

Why I Sold Strategy (MSTR) and Put Money Elsewhere - A Short Trade Plan

Bitcoin's bounce has restored a lot of headline value to bitcoin-linked stocks, but Strategy Inc (MSTR) has started to crystallize gains and change its treasury playbook. That shift, combined with a crowded long position, near-term technical overbought signals, and legal/financial overhangs, creates a compelling tactical short. This note lays out t…

Buy Zhihu on the Q2 Reset: Cheap Valuation and Improving Unit Economics

Buy Zhihu on the Q2 Reset: Cheap Valuation and Improving Unit Economics

Zhihu’s Q2 print showed a small revenue decline and a return to GAAP loss, but paid-content and IP operations expanded, operating expenses fell 13%, and management continued buybacks. At a market cap of roughly $268m and a PB of 0.45, the stock already prices in significant risk. This trade targets a rebound as margins stabilize and monetization fr…